Zhangzhou Pientzehuang Pharmaceutical., Ltd Website

Zhangzhou Pientzehuang Pharmaceutical., Ltd

SHSE-600436

Income Statement
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Operating Revenues

5,705.9

6,492.5

8,004.3

8,674.5

10,036.2

10,638.6

Other Revenues, Total

16.3

18.3

17.3

19.5

22.3

25.2

Total Revenues

5,722.3

6,510.8

8,021.6

8,694

10,058.5

10,663.8

Total Revenues % Chg.

20.1%

13.8%

23.2%

8.4%

15.7%

14.5%

Cost of Goods Sold, Total

3,198.4

3,584.3

3,968

4,734.9

5,363.2

5,808.8

Gross Profit

2,523.8

2,926.5

4,053.6

3,959.1

4,695.3

4,855

Selling General & Admin Expenses, Total

796.2

982.2

1,027.2

814.4

1,149.8

1,130.5

Provision for Bad Debts

2.8

1.9

7.1

-6.8

12.3

12

R&D Expenses

—

—

—

119.4

97.6

199.5

230

232.4

232.3

Other Operating Expenses

45.9

53.2

72.1

72

70.8

49.6

Other Operating Expenses, Total

964.3

1,134.9

1,305.9

1,109.6

1,465.2

1,424.3

Operating Income

1,559.5

1,791.6

2,747.7

2,849.5

3,230.1

3,430.7

Interest Expense, Total

-31.1

-27.4

-32.9

-38

-37.3

-38

Interest And Investment Income

95.3

149.3

144.5

171.6

170.8

169.7

Net Interest Expenses

64.2

121.9

111.6

133.6

133.5

131.7

Currency Exchange Gains (Loss)

4.7

-3.3

-3.3

7.2

3.1

7.4

Other Non Operating Income (Expenses)

-2.7

-4.4

-21.6

-36.5

6

-5.5

EBT, Excl. Unusual Items

1,625.7

1,905.8

2,834.4

2,953.8

3,372.7

3,564.3

Impairment of Goodwill

—

—

—

—

-6.1

—

—

—

—

—

Gain (Loss) On Sale Of Investments

—

-0

6.7

4.5

-0

8.3

12.4

Gain (Loss) On Sale Of Assets

4.6

40.3

27.6

11.1

1.3

3.4

Asset Writedown

—

—

—

—

—

-1

-0.3

—

—

Other Unusual Items

20.4

26.1

3.6

13.2

-13.4

-10.2

EBT, Incl. Unusual Items

1,644.6

1,978.9

2,869

2,977.7

3,368.9

3,570

Income Tax Expense

257.7

289.5

404.2

454.8

517.8

557.5

Earnings From Continuing Operations

1,386.9

1,689.4

2,464.8

2,523

2,851.1

3,012.5

Minority Interest

-12.6

-17.8

-32.9

-50.6

-53.8

-34.5

Net Income

1,374.4

1,671.5

2,431.9

2,472.3

2,797.4

2,978.1

Net Income to Common Incl Extra Items

1,374.4

1,671.5

2,431.9

2,472.3

2,797.4

2,978.1

Net Income to Common Excl. Extra Items

1,374.4

1,671.5

2,431.9

2,472.3

2,797.4

2,978.1

Total Shares Outstanding

603.3

603.3

603.3

603.3

603.3

603.3

Weighted Avg. Shares Outstanding

602.8

603.4

603.4

603

602.9

602.8

Weighted Avg. Shares Outstanding Dil

602.8

603.4

603.4

603

602.9

602.8

EPS

2.3

2.8

4

4.1

4.6

4.9

EPS Diluted

2.3

2.8

4

4.1

4.6

4.9

EBITDA

1,615.4

1,881.8

2,853.9

2,896.8

3,297.9

3,498.5

Effective Tax Rate

15.7%

14.6%

14.1%

15.3%

15.4%

15.6%